Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1981 Aug;73(4):807–810. doi: 10.1111/j.1476-5381.1981.tb08732.x

Antagonism of opiate mydriasis in mice.

A D Korczyn, M Rock
PMCID: PMC2071488  PMID: 7272583

Abstract

1 Morphine-induced mydriasis in mice is antagonized by nalorphine, levallorphan and naloxone in a dose-dependent manner. 2 The relative potency of the three agents is 10:56: 134 respectively, thus being in accordance with other tests of narcotic antagonism. Naloxone has the shortest duration of action. 3 When injected into naive animals, nalorphine (but not levallorphan or naloxone) produces a slight mydriasis. 4 Measurement of the diameter of the pupil in mice seems to be a precise, simple and rapid test for studying narcotic antagonist as well as agonist action and has several advantages over standard methods used for this purpose.

Full text

PDF
807

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aceto M. D., McKean D. B., Pearl J. Effects of opiates and opiate antagonists on the Straub tail reaction in mice. Br J Pharmacol. 1969 Jun;36(2):225–239. doi: 10.1111/j.1476-5381.1969.tb09500.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adler C., Keren O., Korczyn A. D. Tolerance to the Mydriatic effects of morphine in mice. J Neural Transm. 1980;48(1):43–47. doi: 10.1007/BF01670032. [DOI] [PubMed] [Google Scholar]
  3. Blane G. F., Dugdall D. Interactions of narcotic antagonists and antagonist-analgesics. J Pharm Pharmacol. 1968 Jul;20(7):547–552. doi: 10.1111/j.2042-7158.1968.tb09803.x. [DOI] [PubMed] [Google Scholar]
  4. Blumberg H., Dayton H. B. Naloxone, naltrexone, and related noroxymorphones. Adv Biochem Psychopharmacol. 1973;8(0):33–43. [PubMed] [Google Scholar]
  5. FOLDES F. F., LUNN J. N., MOORE J., BROWN I. M. N-Allylnoroxy-morphone: a new potent narcotic antagonist. Am J Med Sci. 1963 Jan;245:23–30. [PubMed] [Google Scholar]
  6. JAGENEAU A., JANSSEN P. A. Mydriatic activity of analgesics in mice. Experientia. 1956 Aug 15;12(8):293–294. doi: 10.1007/BF02159614. [DOI] [PubMed] [Google Scholar]
  7. Jasinski D. R., Martin W. R., Haertzen C. A. The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone). J Pharmacol Exp Ther. 1967 Aug;157(2):420–426. [PubMed] [Google Scholar]
  8. Klemfuss H., Tallarida R. J., Adler C. H., Adler M. W. Morphine-induced mydriasis and fluctuation in the rat: time and dose relationships. J Pharmacol Exp Ther. 1979 Jan;208(1):91–95. [PubMed] [Google Scholar]
  9. Korczyn A. D., Boyman R., Shifter L. Morphine mydriasis in mice. Life Sci. 1979 Apr 30;24(18):1667–1673. doi: 10.1016/0024-3205(79)90251-0. [DOI] [PubMed] [Google Scholar]
  10. Kosterlitz H. W., Watt A. J. Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone). Br J Pharmacol Chemother. 1968 Jun;33(2):266–276. doi: 10.1111/j.1476-5381.1968.tb00988.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES